NCT00584467

Terminated

Genetic and Inflammatory Markers in Cardiovascular Disease (...

University of California, Davis Source

Compare

Other study identifiers

Sponsor study identifier

200513134

Study Type

observational

Actual enrollment (reported)

21

Locations

0 countries

Sites

N/A

Timeline

Study Start

January 2005

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

November 2009

Actual (reported)

Study Completion

November 2009

Actual (reported)

Brief Summary

This is an investigator initiated registry aimed at assembling a blood/serum and genomic resource (bank) of human blood samples with accompanying clinical data mainly from patients who are scheduled to undergo cardiac catheterization at UC Davis Medical Center, but may also include other eligible individuals. Funding is from institutional/divisional research funds.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: terminated
Actual enrollment (reported): 21 participants
Study completion date: November 2009
Actual (reported)
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2005
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
December 26, 2007
Actual (reported)
First Posted
January 2, 2008
Actual (reported)
Primary Completion
November 2009
Actual (reported)
Study Completion
November 2009
Actual (reported)

Last Updated: January 31, 2018
Status Verified: January 2018
Last Update Submitted: January 29, 2018

Conditions

Atherosclerosis

Keywords

GEMArteriosclerosisbiomarkersAtherosclerosis

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Subjects will mainly include individuals who are scheduled to undergo cardiac catheterization at UC Davis Medical Center, but may include other eligible individuals. Subjects may also include individuals who have objective evidence of the extent of arteriosclerosis of the coronary, femoral or carotid arteries.

You may qualify if:

Any individual cared for in the UC Davis Health System
disorders of lipoproteins or arteriosclerosis

You may not qualify if:

Subjects will be excluded only if they refuse to be in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

University of California, San Francisco
Othercollaborator
University of California, Davis
Otherlead

Biospecimen

Retention: SAMPLES WITH DNA

blood/serum

MeSH Terms

Conditions

AtherosclerosisArteriosclerosis

Condition Hierarchy (Ancestors)

Arterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

Jason Rogers, MD
University of California, Davis
PRINCIPAL INVESTIGATOR

Enrollment

21 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

December 26, 2007

First Posted

January 2, 2008

Study Start

January 2005

Date type not reported

This date has not been verified as actual or estimated.

NCT00590616

Utility of Clinical Examination in the Noninvasive Prediction of Aortic Atheroma - A Prospective Study

Completed

NCT00116831

Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes

Phase 3Completed

NCT01916720

Study to Determine the Effect of 14 Days Dosing With Darapladib (SB-480848) on Carotid Plague Composition in Patients With Planned Carotid Endarterectomy

Phase 2Completed

NCT00421278

The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)

Phase 2Completed

NCT00512369

Effects of PA-1 Transcriptional Regulation on Monocyte Function

Terminated

NCT01742000

Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women

Phase 3Completed

Primary Completion

November 2009

Actual (reported)

Study Completion

November 2009

Actual (reported)

Last Updated

January 31, 2018

Record last verified: 2018-01

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00584467
Data provider: ClinicalTrials.gov
Source updated: 2018-01-31
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:22:46 UTC

Genetic and Inflammatory Markers in Cardiovascular Disease (GEM) Registry

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Related Links

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Related Links

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record